Chemokines: Potent mediators of hepatic inflammation and fibrosis in chronic liver diseases

Annals of Hepatology

Volumn 13, Issue 1, 2014, Pages 152-154

  Handa, Priya ^a   Kowdley, Kris V ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE;

CHRONIC LIVER DISEASE; CYTOKINE PRODUCTION; FIBROGENESIS; HEPATITIS; HUMAN; IMMUNOREGULATION; INFLAMMATORY CELL; LEUKOCYTE MIGRATION; LIVER FIBROSIS; LIVER INJURY; MACROPHAGE MIGRATION; NATURAL KILLER T CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CHEMOKINE CXCL6; HUMANS; LIVER CIRRHOSIS; NATURAL KILLER T-CELLS; RECEPTORS, CXCR;

EID: 84893694366     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)30918-4     Document Type: Note

References (14)

1. Berasain C, Castillo J, Perugorria MJ, et al. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 2009; 1155: 206-21.
2. Bieghs V, Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol 2013; 34: 446-52.
3. Liaskou E, Wilson DV, Oo YH. Innate immune cells in liver inflammation. Mediators Inflamm 2012; 2012: 949157.
4. Safadi R, Ohta M, Alvarez CE, et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004; 127: 870-82.
5. Muhanna N, Abu Tair L, Doron S, et al. Amelioration of hepatic fibrosis by NK cell activation. Gut 2011; 60: 90-8.
6. Wehr A, Baeck C, Heymann F, et al. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. J Immunol 2013; 190: 5226-36.
7. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009; 86: 513-28.
8. Godfrey DI, MacDonald HR, Kronenberg M, et al. NKT cells: what's in a name? Nat Rev Immunol 2004; 4: 231-7.
9. no9/no. Wang H, Park O, Gao B. NKT cells in liver fibrosis: contro-versies or complexities. J Hepatol 2011; 55: 1166. Author reply 1166-7
10. Geissmann F, Cameron TO, Sidobre S, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005; 3: e113.
11. Syn WK, Oo YH, Pereira TA, et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010; 51: 1998-2007.
12. Zimmermann HW, Tacke F. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy Drug Targets 2011; 10: 509-36.
13. Sahin H, Trautwein C, Wasmuth HE. Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol 2010; 7: 682-90.
14. Heydtmann M, Lalor PF, Eksteen JA, et al. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 2005; 174: 1055-62.